We work with you to produce all the relevant documentation that needs to be submitted for the required testing procedures.
We support you and, if you wish, we can manage your communications with ethics committees and the relevant national competent authority (e.g. BfArM in Germany) for you.
Your team brings together specialists who have a thorough understanding of the details and generalists who are good at keeping an eye on the big picture.
Your team combines lots of talent, experience and knowledge. When everyone works together, the study will be a success.
Our project managers guide your study for you. They manage your research every day. They maintain an overview of the big picture and notice any unexpected events. Even when everything has been carefully planned, things doesn’t always go according to plan. Your team will be prompt and flexible in discussing the measures that are necessary to get your study back on track with you.
You will receive status reports from us and interim results that document the successful progress of your study.
We maintain contact with the study centres for the entire duration of your study. We take care of the contracts, remuneration and all the formalities.
We monitor patient inclusion, chase things up and provide that bit of encouragement if the number of participants is lower than expected.
Our monitors are there for you at the study centres. They train the staff at the study centres and help the study assistants to gain an understanding of the specific requirements of your study. They make the centres aware of the details of your study and the quality of your data.
Up to five years after inclusion, we telephone patients to collect data for your study and provide you with information about the long-term success of a treatment.
At 95 per cent, our follow-up rate is far above average. Our patient service employees are helpful to the patients. They ask the patients questions in an empathetic and precise manner and this allows them to obtain results for long-term observation within the scope of your study.
First results introduced during the 88th annual meeting of the DGK in Mannheim byProf. Uwe Zeymer, Chairman of the Foundation Institute for Myocardial Infarction Research and Principal Investigator of the GULLIVE-R study.
Read more
Dr. Matthieu Godin and his study team from Clinique Saint Hilaire in Rouen, and Dr. Christophe Robin and his study team from Clinique Convert, of Bourg en Bresse are pleased to announce the successful enrollment of their first patient.
Read more
The design paper of the PASSPORT-HF study has been published.
Read more